Preventing Adolescents From Entering the Juvenile Justice System
NCT ID: NCT02147743
Last Updated: 2014-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2009-05-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Juvenile Detention to Community Life
NCT01910324
Family-Based Juvenile Drug Court Services
NCT01668303
Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System
NCT02672150
Testing a Promising Treatment for Youth Substance Abuse in a Community Setting
NCT02130479
Family-based and Adolescent Residential Drug Treatment
NCT01737632
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study sample includes youth referred to the CCP throughout Miami-Dade county and who according to CCP screening are rated as high risk for re-offending. Youth are 12-17 years old with a first or second misdemeanor charge (excluding any gang, violence, or sex crimes charge). Nearly all (97%) of these youth are ethnic minorities (Hispanic and African American). They are at risk for school failure, substance use, and chronic delinquency due to drug availability in their communities, poor family functioning, peer drug use/delinquency, and school failure / disengagement.
120 youth who enter the Civil Citation Program and are eligible for the study will be assigned to one of the two interventions: CCP+SAU or the experimental intervention, CCP+MDFT.
The study asks a classical services research question(Compton et al, 2005) - does the addition of a family therapy intervention, multidimensional family therapy, into an existing diversion program significantly enhance the program outcomes in key outcome domains: recidivism, substance use, delinquency, school and family functioning.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CCP+MDFT
Multidimensional Family Therapy (MDFT) is a multisystemic, flexible intervention system (Liddle, 2002). It is a strengths-based approach promoting protective factors and reducing risk factors for delinquency, substance use, and school problems. MDFT organizes interventions in key areas of the teen's life: self of the adolescent (includes HIV-STD risk behaviors), parenting, family environment, and school/vocational functioning.
CCP+MDFT
Multidimensional Family Therapy (MDFT; Liddle, 2002) is one of a new generation of multi-systems oriented family-based intervention for adolescent substance abuse and delinquency. It has demonstrated considerable success with juvenile justice youth at various stages of their involvement in the justice system. The model has demonstrated efficacy in reducing substance use and delinquency, increasing the prosocial behaviors (e.g., family functioning, school outcomes) of substance abusing and court involved adolescents.
CCP+SAU
Services as Usual (SAU) are determined on a case-by-case basis by the CCP Case Manager. SAU includes a variety of services offered by a number of community partners.
CCP+SAU
Services As Usual community partners will provide individualized mental health counseling and psychiatric services, psychoeducational groups and substance abuse counseling.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CCP+MDFT
Multidimensional Family Therapy (MDFT; Liddle, 2002) is one of a new generation of multi-systems oriented family-based intervention for adolescent substance abuse and delinquency. It has demonstrated considerable success with juvenile justice youth at various stages of their involvement in the justice system. The model has demonstrated efficacy in reducing substance use and delinquency, increasing the prosocial behaviors (e.g., family functioning, school outcomes) of substance abusing and court involved adolescents.
CCP+SAU
Services As Usual community partners will provide individualized mental health counseling and psychiatric services, psychoeducational groups and substance abuse counseling.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parent or guardian willing to participate in assessments/treatment
* Demonstrate risk for mental health, substance abuse, or anger/adjustment problems on the Juvenile Services Department screening warranting intervention but not requiring residential treatment
Exclusion Criteria
* Parent/guardian not willing to participate in assessments and treatment
* Youth not demonstrating mental health, substance abuse or anger/adjustment problems
* Youth requiring residential treatment
* Youth with severe mental illness or retardation
12 Years
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Howard Liddle
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Howard Liddle, EdD
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Miami Miller School of Medicine
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20080174
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.